Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

You’re Not Missing Out By Waiting for FuboTV Stock to Move Lower

By Will Ashworth, InvestorPlace Contributor

FuboTV’s gamble on sports betting is risky. With FUBO stock down 35% in the past month, should investors buy its stock on the dip?

Times Have Changed for Marathon Digital Holdings, but It’s Still No Buy

By Will Ashworth, InvestorPlace Contributor

A lot has changed for Marathon Digital in recent months. However, a bet on MARA stock is really just a bet on Bitcoin and its future.

The Roblox Experience Is Open for Business

By Will Ashworth, InvestorPlace Contributor

Roblox offered 198.9 million shares for sale March 10 in a direct listing of RBLX stock. Should you buy, regardless of price, after it opens? 

Investing in Ideanomics Isn’t as Terrible an Idea as You May Have Thought

By Will Ashworth, InvestorPlace Contributor

Ideanomics signed an At-the-Market agreement to sell $150 million of IDEX stock. What it does with the money will speak volumes.  

There Are Many Good Reasons Not to Buy AMC Shares

By Will Ashworth, InvestorPlace Contributor

A Wedbush analyst doubled his target price for AMC stock March 8. Despite gaining 15% on the news, there are many good reasons not to buy.   

10 of the Hottest ETFs To Buy Right Now

By Will Ashworth, InvestorPlace Contributor

While the markets haven't gotten off to a super-fast start in 2021, some of the hottest ETFs to buy are available right now.

TransEnterix or Asensus Surgical? Let’s Call the Whole Thing Off

By Will Ashworth, InvestorPlace Contributor

Whether you’re looking to invest in TRXC stock or its successor, Asensus Surgical, you’ll need something to handle the volatility.  

Should VG Acquisition Stock Be Bought on Weakness?

By Will Ashworth, InvestorPlace Contributor

It’s been a month since VG Acquisition announced it was merging with 23andMe. VGAC stock has lost 40% of its value. Does that make it a buy?   

Is Ocugen Worth $18 or Just a Couple of Bucks?

By Will Ashworth, InvestorPlace Contributor

Ocugen's roller-coaster ride continues. OCGN stock lost more than 14% on March 5. Is it an $18 stock or worth just a couple of bucks?  

7 Recession-Proof Stocks to Buy 

By Will Ashworth, InvestorPlace Contributor

The Biden fiscal stimulus should prevent a downturn in 2021. Just in case, here are seven recession-proof stocks to buy. 

Load More